Dose Regimen Rationale for Panitumumab in Cancer Patients: To Be Based on Body Weight or Not

Overview of attention for article published in Clinical Pharmacology : Advances and Applications, July 2020

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 3 Dimensions

Readers on

mendeley: 2 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 1 X post from an account with 198 followers.

A body weight–based approach is the recommended patient dosing strategy for panitumumab (an anti-EGFR mAb). Dose Regimen Rationale for Panitumumab in Cancer Patients: To Be Based on Body Weight or Not https://t.co/AMgulJnpYm

25 Aug 2020

Reply Repost Favourite

Dove Medical Press

Article Metrics

Dose Regimen Rationale for Panitumumab in Cancer Patients: To Be Based on Body Weight or Not

Mentioned by

Citations

Readers on